Page 7 - EASL POSTGRADUATE COURSE
P. 7
WELCOME MESSAGE
The 2015 EASL Postgraduate Course is focused on metabolic liver disease. The EASL
Governing Board selected this topic because metabolic liver disease affects a growing
fraction of the population and many aspects of this disease are still intensely debated.
There is no physician in clinical practice who did not have to care for an increasing number
of patients with metabolic liver disease. While we now understand that this condition is
associated with major changes in our lifestyle within an obesogenic environment, there are
many challenges ahead in terms of understanding the multiple and complex pathogenic
pathways, refining the diagnosis, optimizing non-invasive diagnostic procedures, identifying
patients at risk of disease progression and those in need of specific hepatological therapies.
We would like this Postgraduate Course to highlight many of these clinical practice
dilemmas and to engage the audience with world-renowned experts on how to make the
best management decisions in 2015 to help patients with metabolic liver disease. We are
proud to have assembled an outstanding panel of speakers and hope that you will find this
course stimulating, informative and useful for your everyday practice.
Jean-François Dufour Vlad Ratziu Herbert Tilg
Switzerland France Austria
The International Liver Congress™ 2015 • Vienna, Austria • April 22–23, 2015 7
The 2015 EASL Postgraduate Course is focused on metabolic liver disease. The EASL
Governing Board selected this topic because metabolic liver disease affects a growing
fraction of the population and many aspects of this disease are still intensely debated.
There is no physician in clinical practice who did not have to care for an increasing number
of patients with metabolic liver disease. While we now understand that this condition is
associated with major changes in our lifestyle within an obesogenic environment, there are
many challenges ahead in terms of understanding the multiple and complex pathogenic
pathways, refining the diagnosis, optimizing non-invasive diagnostic procedures, identifying
patients at risk of disease progression and those in need of specific hepatological therapies.
We would like this Postgraduate Course to highlight many of these clinical practice
dilemmas and to engage the audience with world-renowned experts on how to make the
best management decisions in 2015 to help patients with metabolic liver disease. We are
proud to have assembled an outstanding panel of speakers and hope that you will find this
course stimulating, informative and useful for your everyday practice.
Jean-François Dufour Vlad Ratziu Herbert Tilg
Switzerland France Austria
The International Liver Congress™ 2015 • Vienna, Austria • April 22–23, 2015 7
